Literature DB >> 31718355

Antinuclear antibodies in infectious diseases.

Jae Hyoung Im1, Moon-Hyun Chung2, Young Kyoung Park3, Hea Yoon Kwon1, Ji Hyeon Baek1, Seung Yun Lee4, Jin-Soo Lee1.   

Abstract

Introduction: Antinuclear antibody (ANA) tests are widely used for the diagnosis of autoimmune diseases, but ANAs are also commonly found in patients with various infections. This retrospective study aimed to investigate the relationship between infections and ANA status.
Methods: Patients that visited the Department of Infectious Diseases at Inha University Hospital between January 2007 and July 2018 were investigated. We analysed their ANA test results and reviewed rheumatic and infectious diagnoses of patients with positive ANA findings.
Results: Of the 9,320 patients during the study period, 1,111 underwent ANA testing and 110 tested positive. Seven of the 110 patients were previously diagnosed with ANA-positive disease, and 21 were diagnosed with autoimmune disease during the present study. Of the remaining 82 patients, 43 were confirmed with infectious disease. The most common pathogen was Mycobacterium tuberculosis (n = 10), followed by Treponema pallidum (n = 5), Orientia tsutsugamushi (n = 5), Escherichia coli (n = 5), Bartonella henselae (n = 3), and human immunodeficiency virus (n = 3). Of the 39 patients without a confirmed pathogen, 7 were seropositive for O. tsutsugamushi, B. henselae, or Rickettsia spp. Patients were observed at an average of 24 weeks in our hospital. One patient developed systemic lupus erythematosus after being diagnosed with Epstein-Barr virus-induced infectious mononucleosis, and another patient developed adult-onset Still's disease after being diagnosed with scrub typhus.
Conclusion: This study showed that various relationships exist between infections and rheumatic diseases. In particular, several patients with a positive ANA test result were found to have intracellular infections such as mycobacterial infections, syphilis, or scrub typhus.

Entities:  

Keywords:  Antinuclear antibodies; autoimmune diseases; infection; scrub typhus; tuberculosis

Year:  2019        PMID: 31718355     DOI: 10.1080/23744235.2019.1690676

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  10 in total

1.  SARS-CoV-2 infection as a trigger of autoimmune response.

Authors:  Maria C Sacchi; Stefania Tamiazzo; Paolo Stobbione; Lisa Agatea; Piera De Gaspari; Anna Stecca; Ernesto C Lauritano; Annalisa Roveta; Renato Tozzoli; Roberto Guaschino; Ramona Bonometti
Journal:  Clin Transl Sci       Date:  2021-01-21       Impact factor: 4.689

2.  Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19).

Authors:  L Angelica Lerma; Anu Chaudhary; Andrew Bryan; Chihiro Morishima; Mark H Wener; Susan L Fink
Journal:  J Transl Autoimmun       Date:  2020-11-27

3.  Significance of Anti-Nuclear Antibodies and Cryoglobulins in Patients with Acute and Chronic HEV Infection.

Authors:  Thomas Horvatits; Julian Schulze Zur Wiesch; Susanne Polywka; Gustav Buescher; Marc Lütgehetmann; Elaine Hussey; Karoline Horvatits; Sven Peine; Friedrich Haag; Marylyn M Addo; Ansgar W Lohse; Christina Weiler-Normann; Sven Pischke
Journal:  Pathogens       Date:  2020-09-16

4.  Splenic infarction and infectious diseases in Korea.

Authors:  Jae Hyoung Im; Moon-Hyun Chung; Hye-Jin Lee; Hea Yoon Kwon; Ji Hyeon Baek; Ji-Hun Jang; Jin-Soo Lee
Journal:  BMC Infect Dis       Date:  2020-12-02       Impact factor: 3.090

5.  Hygiene Hypothesis Indicators and Prevalence of Antinuclear Antibodies in US Adolescents.

Authors:  Helen C S Meier; Dale P Sandler; Jesse Wilkerson; Frederick W Miller; Gregg E Dinse; Christine G Parks
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

6.  Study of the D-dimer, C-reactive protein, and autoantibodies markers among HBV infected patients in Babylon province, Iraq.

Authors:  Ahmed Abdul-Abbas Bayram; Hussein O M Al-Dahmoshi; Noor S K Al-Khafaji; Raheem Tuama Obayes Al Mammori; Ali Husain Shilib Al-Shimmery; Morteza Saki
Journal:  Biomedicine (Taipei)       Date:  2021-12-01

7.  Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.

Authors:  Gábor J Szebeni; Nikolett Gémes; Dániel Honfi; Enikő Szabó; Patrícia Neuperger; József Á Balog; Lajos I Nagy; Zoltán Szekanecz; László G Puskás; Gergely Toldi; Attila Balog
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

8.  The clinical value of indirect immunofluorescence for screening anti-rods and rings antibodies: A retrospective study of two centers in China.

Authors:  Jingjing Meng; Guoxiang Yang; Siting Li; Yueming Luo; Yina Bai; Chuiwen Deng; Ning Song; Mengtao Li; Xiaofeng Zeng; Chaojun Hu
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

9.  Relapsing symmetric livedo reticularis in a patient with COVID-19 infection.

Authors:  M Verheyden; M Grosber; J Gutermuth; B Velkeniers
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-08-04       Impact factor: 9.228

Review 10.  The Past, Present, and Future in Antinuclear Antibodies (ANA).

Authors:  Juan Irure-Ventura; Marcos López-Hoyos
Journal:  Diagnostics (Basel)       Date:  2022-03-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.